Virtus Biotech ETF closed at $105.02 on Sep 28, up 0.34%, 4.4% below its 52-week closing high. Volume of 17.5K shares was 1.51× its 20-day average (above normal).
Split-adjusted performance: -3.4% over one month, +33.6% over six months, +54.2% over one year.
Short interest was 3.3K shares at the Sep 15 settlement, down 87.9% from the prior report (1.0 days to cover).
No recent articles focused on Virtus Biotech ETF. 1 articles mention it in passing.
Quick answers
What is BBP's market cap?
$126.02M, based on the Sep 28 close of $105.02.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology